工厂供应安全损失重量/脂肪药物奥利司他粉
议价
加入意向| 型号。 | cwlls |
| 定制 | 定制 |
| 适合 | 成人 |
| 纯度 | >99% |
| 交货时间 | 付款后3天内确认 |
| 运输包装 | 10g,50g,100g,500g,1kg防伪包装 |
| 起源 | 中国 |
| 粉末 | 是 |
| 证明 | iso 9001 |
| 州 | 粉末 |
| 价钱 | 面议 |
| 商标 | ChinWon |
| 规范 | 脂肪燃烧和肌肉建设 |
产品描述:
奥利司他(也称为四氢胶抑素)
旨在治疗肥胖。
其主要功能是通过作为脂肪酶抑制剂来阻止人体饮食中的脂肪吸收,从而降低热量摄入。它适用于医疗保健提供者监督的低热量饮食。
奥利司他是脂肪抑素的饱和衍生物,其是从细菌链霉菌(Streptomycestoxytricini)分离的胰脂肪酶的有效天然抑制剂。然而,由于其相对简单和稳定,将奥利司他选择作为抗肥胖药物用于发展的抑脂剂。

应用:
奥利司他在促进体重减轻方面的有效性是明确的,尽管适度。来自临床试验的汇集数据表明,除了饮食和运动之类的生活方式改变之外,给予奥利司他的人比一年中没有服用药物还要大约2-3公斤(4.4-6.6磅).Orlistat也是适度降低血压,似乎可以预防2型糖尿病的发病,无论是由于减肥本身还是其他作用;在一项大型随机对照试验中,奥利司他被发现在肥胖人群中将糖尿病发病率降低近40%。
| 测试项目 | 规范 | 结果 |
描述 | 白色至白色结晶性粉末 | 执行 |
熔点 | 166-170°CDEG; C ^deg;C | 167.3-168.1°CDEG; C ^deg;C |
鉴定 | 积极的反应 | 积极的反应 |
相关物质 | ≤1.0%1.0%1.0% | 0.16% |
干燥失重 | ≤0.5%0.5%0.5% | 0.06% |
炽灼残渣 | ≤0.1%0.1%0.1% | 0.02% |
氯化物 | ≤0.014%014%014% | <0.014 |
重金属 | ≤20ppm0ppm0ppm | <20ppm0ppm |
清晰度的解决方案 | 符合标准 | 符合规定 |
微生物限度 | ≤20ppm0ppm0ppm | <20ppm0ppm |
化验 | ≥99.0%9.0%9.0% | 99.12% |
欢迎通过网站了解更多关于我们。
我希望成为你的商业伙伴。
最好的问候,
忠实于你的 朋友
S叶琳娜 背风处
出口经理
西安ChinWon生物科技有限公司
电话:+86 132 0159 0626
传真:+86 29 6566 4500
网站: www.chinwonbio.com
http://chinwonbio.en.made-in-china.com/
| Model NO. | CWLLS |
| Customized | Customized |
| Suitable for | Adult |
| Purity | >99% |
| Delivery Time | Within 3 Days After Payment Confirmed |
| Transport Package | 10g, 50g, 100g, 500g, 1kg Well Disguised Package |
| Origin | China |
| Powder | Yes |
| Certification | ISO 9001 |
| State | Powder |
| Price | Negotiable |
| Trademark | ChinWon |
| Specification | fat-burning and muscle building |
Product Description:
Orlistat (also known as tetrahydrolipstatin)
is designed to treat obesity.
Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet.
Orlistat is the saturated derivative of lipstatin, a potent natural inhibitor of pancreatic lipases isolated from the bacterium Streptomyces toxytricini. However, due to its relative simplicity and stability, orlistat was chosen over lipstatin for development as an anti-obesity drug.

Application:
The effectiveness of orlistat in promoting weight loss is definite, though modest. Pooled data from clinical trials suggest that people given orlistat in addition to lifestyle modifications, such as diet and exercise, lose about 2-3 kilograms (4.4-6.6 lb) more than those not taking the drug over the course of a year.Orlistat also modestly reduces blood pressure, and appears to prevent the onset of type 2 diabetes, whether due to weight loss itself or to other effects; in a large randomized controlled trial, orlistat was found to reduce the incidence of diabetes by nearly 40% in obese people.
| Test Items | Specification | Results |
Description | White to off white crystalline powder | Comply |
Melting point | 166-170°Cdeg;Cdeg;C | 167.3-168.1°Cdeg;Cdeg;C |
Identification | Positive reaction | Positive reaction |
Related substances | ≤1.0%1.0%1.0% | 0.16% |
Loss on drying | ≤0.5%0.5%0.5% | 0.06% |
Residue on ignition | ≤0.1%0.1%0.1% | 0.02% |
Chloride | ≤0.014%014%014% | <0.014 |
Heavy Metals | ≤20ppm0ppm0ppm | <20ppm0ppm |
Clarity of solution | Conform to standard | Complies |
Microbial Limit | ≤20ppm0ppm0ppm | <20ppm0ppm |
Assay | ≥99.0%9.0%9.0% | 99.12% |
Welcome to know more about us via website.
I hope to be your business partner.
Best and regards,
Your Sincerely Friend
Selina Lee
Exporting Manager
Xi'an ChinWon Biotech Inc.
Tel: +86 132 0159 0626
Fax: +86 29 6566 4500
Website: www.chinwonbio.com
http://chinwonbio.en.made-in-china.com/